Los Angeles Convention Center
Los Angeles, CA
May 16-20, 2023

Ever since it was founded in 2003, Biovian has been dedicated to providing CDMO excellence in biopharmaceutical manufacturing. Biovian especially focuses on viral vector production (Adenovirus and AAV), microbial production of recombinant proteins, and plasmid DNA. We are experts in process development, scale-up, clinical manufacturing as well as technology transfer, and we cover both Drug Substance and Drug Product manufacturing. Guided by our Nordic ethos we have established a reputation for delivering high-quality work on time and within budget to a global client base.